ATE284206T1 - Transdermal verabreichtes dextromethorphan als hustenmittel - Google Patents

Transdermal verabreichtes dextromethorphan als hustenmittel

Info

Publication number
ATE284206T1
ATE284206T1 AT97915801T AT97915801T ATE284206T1 AT E284206 T1 ATE284206 T1 AT E284206T1 AT 97915801 T AT97915801 T AT 97915801T AT 97915801 T AT97915801 T AT 97915801T AT E284206 T1 ATE284206 T1 AT E284206T1
Authority
AT
Austria
Prior art keywords
cough medicine
dextromethorphan
administered dextromethorphan
transdermal
morphanin
Prior art date
Application number
AT97915801T
Other languages
English (en)
Inventor
Ulla Hoeck
Bo Kreilgard
Helle Kristensen
Original Assignee
Pfizer Health Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab
Application granted granted Critical
Publication of ATE284206T1 publication Critical patent/ATE284206T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT97915801T 1996-04-23 1997-03-21 Transdermal verabreichtes dextromethorphan als hustenmittel ATE284206T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601528A SE9601528D0 (sv) 1996-04-23 1996-04-23 Transdermally administered dextromethorphan as antitissue agent
PCT/SE1997/000484 WO1997039742A1 (en) 1996-04-23 1997-03-21 Transdermally administered dextromethorphan as antitussive agent

Publications (1)

Publication Number Publication Date
ATE284206T1 true ATE284206T1 (de) 2004-12-15

Family

ID=20402295

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97915801T ATE284206T1 (de) 1996-04-23 1997-03-21 Transdermal verabreichtes dextromethorphan als hustenmittel

Country Status (14)

Country Link
US (1) US6335030B1 (de)
EP (1) EP0904067B1 (de)
JP (1) JP2000509037A (de)
AT (1) ATE284206T1 (de)
AU (1) AU714942B2 (de)
CA (1) CA2251966C (de)
DE (1) DE69731882T2 (de)
DK (1) DK0904067T3 (de)
ES (1) ES2234012T3 (de)
NZ (1) NZ332215A (de)
PT (1) PT904067E (de)
SE (1) SE9601528D0 (de)
WO (1) WO1997039742A1 (de)
ZA (1) ZA973444B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
GB9920167D0 (en) * 1999-08-25 1999-10-27 Avery Dennison Corp Pressure sensitive adhesive compositions
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
US8133505B2 (en) * 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US7662404B2 (en) * 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US8502681B2 (en) * 2005-06-20 2013-08-06 Biovigil, Llc Hand cleanliness
JP5015620B2 (ja) * 2007-01-30 2012-08-29 株式会社クラレ 皮膚外用剤
US20100160368A1 (en) 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
MX2011001555A (es) 2008-12-19 2011-04-14 Graceway Pharmaceuticals Llc Formulaciones de imiquimod de baja concentracion de dosis y regimenes de dosis de corta duracion para tratar queratosis actinica.
EP2453747B1 (de) 2009-07-13 2017-08-30 Medicis Pharmaceutical Corporation Imiquimod-formulierungen mit geringerer dosisstärke und kurze dosierpläne zur behandlung von warzen im genital- und perianalbereich
US8461102B2 (en) * 2010-03-02 2013-06-11 George E. Royster, JR. Methods and compositions for treating and preventing symptoms of hormonal variations
US10493049B2 (en) 2016-02-10 2019-12-03 Niracle LLC Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
TWI795446B (zh) * 2017-10-04 2023-03-11 美商神經治療股份有限公司 右旋美索芬(dextromethorphan)經皮輸送裝置
AU2021249031A1 (en) * 2020-03-30 2022-11-10 Shinkei Therapeutics, Inc Transdermal delivery of dextromethorphan
CN117545474A (zh) 2021-11-08 2024-02-09 李维庸 一种用于向患者递送药物的透皮给药系统

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275510A (en) * 1966-09-27 Topical antitussive preparations
US2676177A (en) 1949-11-09 1954-04-20 Hoffmann La Roche Process for the preparation of optically active 3-methoxy-n-methyl morphinans and salts thereof
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
JPS6351327A (ja) * 1986-08-22 1988-03-04 Sato Seiyaku Kk 液状組成物
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
US4888354A (en) 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
US4915950A (en) 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5164406A (en) 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
EP0351897A3 (de) 1988-06-17 1990-03-21 The Procter & Gamble Company Hautpenetrierendes System für aminfunktionelle Anrzneistoffsalze
US5213568A (en) 1990-03-30 1993-05-25 Medtronic Inc. Activity controlled electrotransport drug delivery device
WO1991015261A1 (en) * 1990-03-30 1991-10-17 Medtronic, Inc. Activity controlled electrotransport drug delivery device
EP0555411A1 (de) * 1990-10-31 1993-08-18 The Procter & Gamble Company Dextromethorphan enthaltende hustenstillende zusammensetzungen
GB9103302D0 (en) * 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
EP0608320B1 (de) 1991-10-16 1998-01-28 Richardson-Vicks, Inc. Verbesserte hautpenetrationssysteme fuer erhoehte topische freisetzung von arzneimitteln
EG20380A (en) 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
US5260066A (en) 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
US5756117A (en) * 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
AU7568394A (en) 1993-08-19 1995-03-14 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity

Also Published As

Publication number Publication date
ES2234012T3 (es) 2005-06-16
EP0904067A1 (de) 1999-03-31
JP2000509037A (ja) 2000-07-18
AU714942B2 (en) 2000-01-13
DE69731882D1 (de) 2005-01-13
CA2251966C (en) 2008-01-15
DK0904067T3 (da) 2005-03-14
NZ332215A (en) 2000-09-29
ZA973444B (en) 1997-11-18
PT904067E (pt) 2005-02-28
EP0904067B1 (de) 2004-12-08
US6335030B1 (en) 2002-01-01
CA2251966A1 (en) 1997-10-30
SE9601528D0 (sv) 1996-04-23
DE69731882T2 (de) 2005-12-15
WO1997039742A1 (en) 1997-10-30
AU2313297A (en) 1997-11-12

Similar Documents

Publication Publication Date Title
ATE284206T1 (de) Transdermal verabreichtes dextromethorphan als hustenmittel
ES2137261T3 (es) Administracion transdermica de oxibutinina.
NZ508526A (en) Opioid formulations for treating pain
UA26988C2 (uk) Спосіб седативhого впливу hа пацієhта і траhсдермальhа терапевтичhа система
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DK0946151T3 (da) Doseringsform med stigende dosisfrigivelse
GR3032523T3 (en) Therapeutic preparation for the transdermal administration of active substances
WO2001013909A3 (en) Compositions and methods for treating opiate intolerance
PT957899E (pt) Forma de dosagem para proporcionar um medicamento numa dose crescente
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
NO925038L (no) Anordning for nedsettelse av medikamentets hudirriterendevirkninger
DK0754034T3 (da) Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse
DK0871507T3 (da) Rygmarvsnål
GEP20002229B (en) Synthetic Membrane Vesicles, Method for Obtaining and Application of the Same
RU95105973A (ru) Способ снижения тяжести токсоплазмоза, фармацевтическая композиция, применение производных рифамицина для получения лекарственных препаратов для лечения токсоплазмоза
SE9601527D0 (sv) Transdermally alministered acetylcysteine as mucolytic agent
DK408188A (da) Injicerbart middel til kontrolleret frigivelse af opioid-analgetika
EP0906757A3 (de) Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält
SE8804640L (sv) Laekemedel omfattande cyklolinopeptide a
UA26886C2 (uk) Солі 1,3-діарил-4,5-поліметилеhімідазолію, що виявляють аhальгезуючу активhість
UA38897A (uk) Спосіб профілактики дисемінації злоякісних пухлин при діагностичних та хірургічних втручаннях
UA31638A (uk) Спосіб лікування увеїтів
KR920002163A (ko) 의약을 제조하기 위해 중추 신경 작용성 acth 유사체를 사용하는 방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0904067

Country of ref document: EP

REN Ceased due to non-payment of the annual fee